CARENORTH is a northern European (Gdansk/Göteborg/Malmö/Oslo) research collaboration based on a desire to advance the knowledge on the pathophysiology and management of hypertension. The project will be based on the collection of a population based patient CV risk cohort in Northern Poland (Gdansk area) and utilization of available hypertension and population cohorts (NORDIL, CAPPP, MPP, MDC from Göteborg and Malmö areas), for elucidation of novel risk factors and indicators for cardiovascular as well as cerebrovascular disease. Further, the CARENORTH consortium will seek suitable collaboration with research groups globally to work in large collaborations in order to achieve the desired research objectives below.

Research Objectives

• To achieve one part of the project objective by organizing and examining a new patient cohort, based on a large high risk hypertension/CV cohort in the greater Gdansk area
• To achieve the other part of the main research objective by identifying and validating novel risk markers from large scale Scandinavian cohorts such as CAPPP, NORDIL and others by extracting samples available in blood banks and work up patient outcome data from the existing data bases
• To organize a sample/DNA bank based on NORDIL, CAPPP and similar cohorts for Case Control studies and participation in GWAS consortia
• To search active global research collaboration with suitable external partners in the research area of novel CV risk markers

The Key Success Factors

The success factors for CARENORTH are to achieve a platform of highly representative and well examined population and medical case cohorts for physical examination and blood sampling in order to perform classical and genomics risk factor research in hypertensive patients It is essential to work up existing patient platforms and intelligently and carefully collect novel that such a platform will attract professionals to the site for expert advice and downloading which will make it attractive for advertising by product and service companies such as pharma and medical device companies as well as recruiting, insurance companies and similar actors on the market.